The Real-world Treatment Satisfaction by Gefapixiant in RCC
Conditions
Chronic Cough
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Nagoya City University, Nagoya, Aichi-ken, Japan
Contact: Study coordinator (Yoshihiro Kanemitsu, MD, PhD) · kaney32@med.nagoya-cu.ac.jp · +81-52-853-8216Nagoya City University Hospital, Nagoya, Aichi-ken, Japan
Contact: Study coordinator (Kanemitsu Yoshihiro, MD, PhD) · kaney32@med.nagoya-cu.ac.jp · +81-52-85308216
Study leads
Yoshihiro Kanemitsu
Principal Investigator
Nagoya City University Graduate School of Medical Sciences and Medical School